1394820-99-5

Basic information

• Product Name: 1-((4-(2-fluoro-4-nitrophenoxy)quinolin-7-yl)oxy)-2-Methylpropan-2-ol
• Synonyms: 1-((4-(2-fluoro-4-nitrophenoxy)quinolin-7-yl)oxy)-2-Methylpropan-2-ol
• CAS NO: 1394820-99-5
• Molecular Weight: 372.353
• Mol File: 1394820-99-5.mol
• Article Data: 4

Chemical Properties

• CAS DataBase Reference: 1-((4-(2-fluoro-4-nitrophenoxy)quinolin-7-yl)oxy)-2-Methylpropan-2-ol(CAS DataBase Reference)
• NIST Chemistry Reference: 1-((4-(2-fluoro-4-nitrophenoxy)quinolin-7-yl)oxy)-2-Methylpropan-2-ol(1394820-99-5)
• EPA Substance Registry System: 1-((4-(2-fluoro-4-nitrophenoxy)quinolin-7-yl)oxy)-2-Methylpropan-2-ol(1394820-99-5)

Safety Data

• Hazardous Substances Data: 1394820-99-5(Hazardous Substances Data)

Usage

Description

1-((4-(2-fluoro-4-nitrophenoxy)quinolin-7-yl)oxy)-2-Methylpropan-2-ol is a complex chemical compound characterized by a quinoline ring with a fluoro-nitrophenyl group attached and a hydroxy group linked to a 2-methylpropan-2-ol molecule. This unique structure and reactivity suggest potential applications in pharmaceutical or chemical research. However, due to its potential hazardous properties, it should be handled and used with caution in a controlled laboratory setting by trained professionals.

Uses

Used in Pharmaceutical Research:
1-((4-(2-fluoro-4-nitrophenoxy)quinolin-7-yl)oxy)-2-Methylpropan-2-ol is used as a compound for pharmaceutical research due to its unique molecular structure and reactivity, which may contribute to the development of new drugs or therapeutic agents.
Used in Chemical Research:
1-((4-(2-fluoro-4-nitrophenoxy)quinolin-7-yl)oxy)-2-Methylpropan-2-ol is used as a compound for chemical research to explore its reactivity and potential applications in various chemical processes and reactions.

Upstream product

• 1394820-98-4 4-(2-fluoro-4-nitrophenoxy)quinolin-7-ol 
• 1039046-51-9 4-(2-fluoro-4-nitrophenoxy)-7-methoxyquinoline 
• 403-19-0 2-fluoro-4-nitrophenol 
• 181950-57-2 4-chloro-7-hydroxyquinoline 
• 558-30-5 2-methyl-1,2-epoxypropane 
• 909345-85-3 5-((3-(benzyloxy)phenylamino)methylene)-2,2-dimethyl-1,3-dioxane-4,6-dione 
• 178984-56-0 7-(benzyloxy)-4-chloroquinoline 
• 749922-34-7 7-(benzyloxy)quinolin-4-ol 
• 1484-26-0 3-(benzyloxy)aniline 

Downstream Products

• 1394821-00-1 1-((4-(4-amino-2-fluorophenoxy)quinolin-7-yl)oxy)-2-methylpropan-2-ol 
• 1394820-69-9 N-(3-fluoro-4-((7-(2-hydroxy-2-methylpropoxy)quinolin-4-yl)oxy)phenyl)-1,5-dimethyl-3-oxo-2-phenyl-2,3-dihydro-1H-pyrazole-4-carboxamide 

Relevant articles and documents

Oral liquid containing naphthyridine compound and preparation method thereof

The invention relates to the field of medicines, in particular to oral liquid containing naphthyridine compounds and a preparation method of the oral liquid. Every 100 mL of the oral liquid containing the naphthyridine compound is prepared from the following raw materials: 40 to 70 g of pharmaceutically acceptable salt of 5-((3-fluoro-4-((7-(2-hydroxy-2-methylpropyl) quinoline-4-yl) oxo) phenyl) amino)-3-(4-fluorophenyl)-1, 6-naphthyridine-4 (1H)-ketone, 5 to 10 g of stabilizer and 0.3 to 6 g of solubilizer. A pH regulator is used for regulating the pH value to 5.5-6.2; according to the oral liquid containing the naphthyridine compounds, the pH value of the oral liquid containing the naphthyridine compounds is adjusted to 5.5-6.2, and the dosage of each raw material is limited, so that the stability of the oral liquid containing the naphthyridine compounds can be remarkably improved.

Naphthyridine compound and pharmaceutical composition as well as applications thereof

The invention relates to the field of biological medicines and discloses a naphthyridine compound and a pharmaceutical composition as well as applications thereof. The naphthyridine compound has a structure shown in a formula (I) or a stereisomer, a geometric isomer, a tautomer, nitric oxide, hydrate, solvate, metabolite, a pharmaceutically acceptable salt or a prodrug. The naphthyridine compound disclosed by the invention has an anti-tumor effect which is obviously superior to the anti-tumor effect of the prior art. And moreover, the naphthyridine compound disclosed by the invention can treat diseases mediated by protein kinase.